American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Head to Head Review: Tigo Energy (NASDAQ:TYGO) vs. NXP Semiconductors (NASDAQ:NXPI)

Head to Head Review: Tigo Energy (NASDAQ:TYGO) vs. NXP Semiconductors (NASDAQ:NXPI)

NXP Semiconductors (NASDAQ:NXPI – Get Free Report) and Tigo Energy (NASDAQ:TYGO – Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two businesses based... More of this article »
Image about Contrasting Bank of New York Mellon (NYSE:BK) and QCR (NASDAQ:QCRH)

Contrasting Bank of New York Mellon (NYSE:BK) and QCR (NASDAQ:QCRH)

Bank of New York Mellon (NYSE:BK – Get Free Report) and QCR (NASDAQ:QCRH – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk,... More of this article »
Image about Drilling Tools International (DTI) & Its Rivals Head to Head Contrast

Drilling Tools International (DTI) & Its Rivals Head to Head Contrast

Drilling Tools International (NASDAQ:DTI – Get Free Report) is one of 23 public companies in the “Oil & gas field machinery” industry, but how does it weigh in compared to its peers? We will compare Drilling... More of this article »
Image about Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of “Buy” by Brokerages

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of “Buy” by Brokerages

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have... More of this article »
Image about Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Rating of “Hold” from Brokerages

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Rating of “Hold” from Brokerages

Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) have earned an average rating of “Hold” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Six investment... More of this article »
Image about Innergex Renewable Energy Inc. (TSE:INE) Receives Average Recommendation of “Moderate Buy” from Analysts

Innergex Renewable Energy Inc. (TSE:INE) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Innergex Renewable Energy Inc. (TSE:INE – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat reports. Two... More of this article »
Image about Lantronix, Inc. (NASDAQ:LTRX) Receives Consensus Recommendation of “Buy” from Analysts

Lantronix, Inc. (NASDAQ:LTRX) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Lantronix, Inc. (NASDAQ:LTRX – Get Free Report) have received an average rating of “Buy” from the six analysts that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the... More of this article »
Image about Safehold Inc. (NYSE:SAFE) Given Average Rating of “Moderate Buy” by Analysts

Safehold Inc. (NYSE:SAFE) Given Average Rating of “Moderate Buy” by Analysts

Shares of Safehold Inc. (NYSE:SAFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, MarketBeat.com reports. Four research... More of this article »
Image about Ambev S.A. (NYSE:ABEV) Receives Average Rating of “Hold” from Brokerages

Ambev S.A. (NYSE:ABEV) Receives Average Rating of “Hold” from Brokerages

Shares of Ambev S.A. (NYSE:ABEV – Get Free Report) have been given an average recommendation of “Hold” by the seven brokerages that are presently covering the stock, Marketbeat reports. Four analysts have rated the... More of this article »
Image about adidas AG (OTCMKTS:ADDYY) Given Consensus Recommendation of “Buy” by Analysts

adidas AG (OTCMKTS:ADDYY) Given Consensus Recommendation of “Buy” by Analysts

adidas AG (OTCMKTS:ADDYY – Get Free Report) has been given a consensus recommendation of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. Eight research analysts have rated... More of this article »
Image about Element Solutions Inc (NYSE:ESI) Given Average Rating of “Moderate Buy” by Analysts

Element Solutions Inc (NYSE:ESI) Given Average Rating of “Moderate Buy” by Analysts

Element Solutions Inc (NYSE:ESI – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Two investment... More of this article »
Image about Alamos Gold Inc. (TSE:AGI) Given Consensus Rating of “Moderate Buy” by Analysts

Alamos Gold Inc. (TSE:AGI) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Alamos Gold Inc. (TSE:AGI – Get Free Report) (NYSE:AGI) have received a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, MarketBeat Ratings... More of this article »
Image about Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Rating of “Moderate Buy” from Analysts

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that are covering the firm, Marketbeat Ratings reports. Two research... More of this article »
Image about Smith Douglas Homes Corp. (NYSE:SDHC) Receives Consensus Rating of “Hold” from Brokerages

Smith Douglas Homes Corp. (NYSE:SDHC) Receives Consensus Rating of “Hold” from Brokerages

Smith Douglas Homes Corp. (NYSE:SDHC – Get Free Report) has earned a consensus recommendation of “Hold” from the six research firms that are presently covering the company, Marketbeat.com reports. Five research analysts... More of this article »
Image about Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Consensus Rating of “Moderate Buy” from Analysts

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Consensus Rating of “Moderate Buy” from Analysts

Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat reports. One investment... More of this article »